NCT06593951
- Conditions
- Brain Diseases, CSTB-related Disease, Central Nervous System Diseases, +23 more
- Locations
-
- Boston Childrens Hospital Boston, Massachusetts, United States
Clinical trial condition
Myoclonic Epilepsies, Progressive
Explore clinical trials studying Myoclonic Epilepsies, Progressive. Study availability and eligibility vary by location and protocol.
8 public trials
1 recruiting study
Myoclonic Epilepsies, Progressive trial results
NCT05873062
- Conditions
- Brain Diseases, Central Nervous System Diseases, Epilepsies, Myoclonic, +6 more
- Locations
-
- University of Pennsylvania, Penn Epilepsy Center Philadelphia, Pennsylvania, United States
Completed
Brivaracetam as add-on Treatment of Unverricht-Lundborg Disease (ULD) in Adolescents and Adults
NCT00368251
- Conditions
- Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
- Locations
-
- 135 San Francisco, California, United States
- 133 Gainesville, Florida, United States
- 132 New York, United States
- 131 Charlottesville, Virginia, United States
Completed
Clinical and Genetic Studies of Familial Presenile Dementia With Neuronal Inclusion Bodies
NCT00006176
- Conditions
- Alzheimer Disease, Brain Diseases, Central Nervous System Diseases, +17 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
NCT00357669
- Conditions
- Brain Diseases, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +16 more
- Locations
-
- Kuopio, Finland
- Tampere, Finland
- Marseille, France
- Montpellier, France
Active, Not Recruiting
Personalized Antisense Oligonucleotide for A Single Participant With ATN1 Gene Mutation
NCT07084311
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dentatorubral-Pallidoluysian Atrophy, +6 more
- Locations
-
- Hawaii Pacific Neuroscience Honolulu, Hawaii, United States
Active, Not Recruiting
Personalized Antisense Oligonucleotide Therapy for A Single Participant With ATN1 Gene Mutation
NCT06706388
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dentatorubral-Pallidoluysian Atrophy, +6 more
- Locations
-
- Columbia University New York, United States
Active, Not Recruiting
Personalized Antisense Oligonucleotide for A Single Participant (nL62541) With ATN1 Gene Mutation
NCT07221760
- Conditions
- Brain Diseases, Central Nervous System Diseases, Dentatorubral-Pallidoluysian Atrophy, +6 more
- Locations
-
- Dell Children's Austin, Texas, United States